Issue Navigation
-
Review
-
281-288
Drug discovery to treat COVID-19 two years after its outbreak
Gao JJ, Sun FS
Drug Discov Ther. 2021; 15(6):281-288.
DOI: 10.5582/ddt.2021.01302
-
289-299
Xu YY, Yang L, Wang LF, Chen FH
Drug Discov Ther. 2021; 15(6):289-299.
DOI: 10.5582/ddt.2021.01099
-
300-309
Dual targeting, a new strategy for novel PARP inhibitor discovery
Wei LN, Wang MZ, Wang QY, Han ZW
Drug Discov Ther. 2021; 15(6):300-309.
DOI: 10.5582/ddt.2021.01100
-
310-316
Paul SS, Mohan-Lal B, Ray A, Meena VP, Garg RK, Tiwari P, Sirohiya P, Vig S, Bhatnagar S, Mohan A, Vyas S, Wig N
Drug Discov Ther. 2021; 15(6):310-316.
DOI: 10.5582/ddt.2021.01105
-
317-324
Ngamratanapaiboon S, Yambangyang P
Drug Discov Ther. 2021; 15(6):317-324.
DOI: 10.5582/ddt.2021.01101
-
325-330
Shogenji M, Yoshida M, Kato M
Drug Discov Ther. 2021; 15(6):325-330.
DOI: 10.5582/ddt.2021.01104
-
331-336
CASC5 is a potential cancer-testis gene in human urinary bladder transitional cell carcinoma
Singh PK, Bhatt ML, Singh P, Rath SK, Dalela D, Goel MM
Drug Discov Ther. 2021; 15(6):331-336.
DOI: 10.5582/ddt.2021.01108
-
337-340
Matsumoto Y, Kizaki H, Ikeda Y, Nakamura S, Kina S, Nagai T, Nasu T, Miyamoto K, Hori S
Drug Discov Ther. 2021; 15(6):337-340.
DOI: 10.5582/ddt.2021.01102
-
341-343
Entomophthoramycosis: An unusual cause of facial disfigurement
Mondal A, Basu A, Mandal M, Mallik A, Modak DC, Pal D, Majumder D, Guha SK
Drug Discov Ther. 2021; 15(6):341-343.
DOI: 10.5582/ddt.2021.01095